Skip To Main Content
Campus
  • Utbildning
  • Artiklar
Campus
  • Utbildning
  • Artiklar
View Full Results
Sort by

Filtera

Återställ
  • Filtera
  • Innehållstyp
How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

Summary of The UK Prospective Diabetes Study (UKPDS).

Läs mer
Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Summary of Aschner P, et al. Diabetologia. 2020;63(4):711-721.

Läs mer
The Hematology Podcast - Season 3

The Hematology Podcast - Season 3

Läs mer
The Hematology Podcast - Season 4

The Hematology Podcast - Season 4

Läs mer
Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?

Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?

(Based on the study: Stratton IM, et al. BMJ. 2000;321(7258):405-12).

Läs mer
Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi

Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi

Läs mer
Preventive Cardiology: Key Insights from Professor Michal Vrablik

Preventive Cardiology: Key Insights from Professor Michal Vrablik

Läs mer
The Complex Burden of Autoimmune Type 1 Diabetes

The Complex Burden of Autoimmune Type 1 Diabetes

Läs mer
Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

Navigating the Complexities of Smell Loss in Patients with CRSwNP.

Läs mer
Dupilumab och dosering

Dupilumab och dosering

Läs mer
Personalized approach in T2D is key for success

Personalized approach in T2D is key for success

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.

Läs mer
The Long-Term Impact of Early-Onset Atopic Dermatitis

The Long-Term Impact of Early-Onset Atopic Dermatitis

A recent study led by professor Jonathan Silverberg involving over 30,000 participants has highlighted the significant psychosocial burden faced by adults with early-onset atopic dermatitis (AD). Learn more and continue reading.

Läs mer